Sadahisa Ogasawara

26PUBLICATIONS
77CO-AUTHORS
Japanese languageCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biochemistry - lipidsEmergency medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 24, 2026
Discordance Between Japanese and European Definitions of Acute-on-Chronic Liver Failure in Alcohol-Related Cirrhosis: Insights From a 10-Year Consecutive Cohort.

|Jun 02, 2026
Phase Ib/II trial to evaluate the safety and efficacy of atezolizumab and bevacizumab as adjuvant therapy following carbon-ion radiotherapy in hepatocellular carcinoma (VANGUARD): study protocol.

|Apr 03, 2026
Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinoma.

Haruka Anzai, Chihiro Miwa, Sadahisa Ogasawara

|Mar 02, 2026
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study.

Richard S Finn, Masatoshi Kudo, Ivan Borbath

|Feb 18, 2026
Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular Carcinoma.

Masanori Inoue, Sadahisa Ogasawara, Kazuhisa Asahara

|Jan 06, 2026
Cholestasis-reducing effects of bezafibrate on survivors of biliary atresia with native livers: A prospective phase II trial.

Yunosuke Kawaguchi, Keita Terui, Takashi Fumita

Pageof 5

Frequent Collaborators

4 joint publications

Masato Nakamura

3 joint publications

Masanori Atsukawa

3 joint publications

Yoshihito Ozawa

3 joint publications

Michihisa Moriguchi